The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Open accessAbstract
Adult cancers may derive from stem or early progenitor cells. Epigenetic modulation of gene expression is essential for normal function of these early cells but is highly abnormal in cancers, which often show aberrant promoter CpG island hypermethylation and transcriptional silencing of tumor suppressor genes and pro-differentiation factors. We find that for such genes, both normal and malignant embryonic cells generally lack the hypermethylation of DNA found in adult cancers. In embryonic stem cells, these genes are held in a 'transcription-ready' state mediated by a 'bivalent' promoter chromatin pattern consisting of the repressive mark, histone H3 methylated at Lys27 (H3K27) by Polycomb group proteins, plus the active mark, methylated H3K4. However, embryonic carcinoma cells add two key repressive marks, dimethylated H3K9 and trimethylated H3K9, both associated with DNA hypermethylation in adult cancers. We hypothesize that cell chromatin patterns and transient silencing of these important regulatory genes in stem or progenitor cells may leave these genes vulnerable to aberrant DNA hypermethylation and heritable gene silencing during tumor initiation and progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hypermethylated regions (HyperDMRs) in HCC were enriched in the promoters of developmental genes and in genic features such as untranslated regions (UTRs) and exons (Fig. 1b and Supplementary Fig. 2f)47,48.”
From Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential (2025) · cites this paper as [47]
In the citing paper
“Inhibitors of DNMT, LSD1 and EZH2 can derepress endogenous retroviral elements (ERVs) leading to activation of endogenous anti-viral RNA sensing pathways and tumour type I interferon production, which acts in an autocrine manner to drive expression of interferon stimulated genes (ISGs) 191-193,226 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [226]
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
Self-citationA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1279 · Cited by 2,404
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,358
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1799 · Cited by 1,657
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 999
Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus
Baba, S., Yamada, Y., Hatano, Y., Miyazaki, Y., Mori, H., Shibata, T., & Hara, A. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01171.x · Cited by 45
Zhou, J., Zhang, H., Gu, P., Margolick, J. B., Yin, D., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0072-8 · Cited by 45
Tao, Y., Liu, S., Briones, V. R., Geiman, T. M., & Muegge, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr611 · Cited by 45
Ye, Y., McDevitt, M. A., Guo, M., Zhang, W., Galm, O., Gore, S. D., Karp, J. E., Maciejewski, J. P., Kowalski, J., Tsai, H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1153 · Cited by 45
Self-citationMolecular marks for epigenetic identification of developmental and cancer stem cells
Patra, S. K., Deb, M., & Patra, A. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0016-0 · Cited by 44
Aging and cancer epigenetics: Where do the paths fork?
Pérez, R. F., Tejedor, J. R., Fernández, A. F., & Fraga, M. F. (2022) · Aging Cell · doi:10.1111/acel.13709 · Cited by 44
DNA Methylation Changes and Inflammaging in Aging-Associated Diseases
Alimohammadi, M., Makaremi, S., Rahimi, A. A. R., Asghariazar, V., Taghadosi, M., & Safarzadeh, E. (2022) · Epigenomics · doi:10.2217/epi-2022-0143 · Cited by 44
Grimm, C., Chávez, L., Vilardell, M., Farrall, A. L., Tierling, S., Böhm, J. W., Grote, P., Lienhard, M., Dietrich, J., Timmermann, B., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003250 · Cited by 43
Zheng, Y., He, L., Wan, Y., & Song, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0172 · Cited by 43
Remodeling of the Methylation Landscape in Breast Cancer Metastasis
Reyngold, M., Turcan, Ş., Giri, D. D., Kannan, K. S., Walsh, L. A., Viale, A. J., Drobnjak, M., Vahdat, L. T., Lee, W., & Chan, T. A.-T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103896 · Cited by 43
Progressive age-dependent DNA methylation changes start before adulthood in mouse tissues
Takasugi, M. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.12.003 · Cited by 43
Epigenetic stability of embryonic stem cells and developmental potential
Pannetier, M., & Feil, R. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.09.003 · Cited by 42
Regulation of Stem Cell Differentiation by Histone Methyltransferases and DemethylasesPreprint
Pasini, D., Bracken, A. P., Agger, K., Christensen, J. F., Hansen, K. H., Cloos, P. A., & Helin, K. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.009 · Cited by 45
PRC2, Chromatin Regulation, and Human Disease: Insights From Molecular Structure and Function
Liu, X., & Liu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.894585 · Cited by 48
Shoaib, S., Ansari, M. A., Ghazwani, M., Hani, U., Jamous, Y. F., Alali, Z., Wahab, S., Ahmad, W., Weir, S. A., Alomary, M. N., et al. (2023) · Cancers · doi:10.3390/cancers15030697 · Cited by 42
Chomiak, A. A., Tiedemann, R. L., Liu, Y., Kong, X., Cui, Y., Wiseman, A. K., Thurlow, K. E., Cornett, E. M., Topper, M. J., Baylin, S. B., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk4423 · Cited by 44
Self-citationEpigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer
Calmon, M. F., Jeschke, J., Zhang, W., Dhir, M., Siebenkäs, C., Herrera, A., Tsai, H.-C., O’Hagan, H. M., Pappou, E. P., Hooker, C. M., et al. (2015) · Epigenetics · doi:10.1080/15592294.2015.1050173 · Cited by 42
Self-citationChou, J.-L., Chen, L.-Y., Lai, H., & Chan, M. W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525353 · Cited by 42
Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease
Barnett, M. P. G., Bermingham, E. N., McNabb, W. C., Bassett, S. A., Armstrong, K., Rounce, J. R., & Roy, N. C. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.02.006 · Cited by 42
Methylation profile of DNA repetitive elements in human testicular germ cell tumor
Ushida, H., Kawakami, T., Minami, K., Chano, T., Okabe, H., Okada, Y., & Okamoto, K. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20831 · Cited by 42
Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.
Leick, M. B., Shoff, C. J., Wang, E., Congress, J. L., & Gallicano, G. I. (2012) · Europe PMC (PubMed Central) · Cited by 42
Polycomb genes, miRNA, and their deregulation in B-cell malignancies
Wang, G. G., Konze, K. D., & Tao, J. (2015) · Blood · doi:10.1182/blood-2014-10-606822 · Cited by 42
Heterogeneous epigenetic regulation ofTIMP3in prostate cancer
Shinojima, T., Yu, Q., Huang, S. K., Li, M., Mizuno, R., Liu, E. T., Hoon, D. S. �., & Lessard, L. (2012) · Epigenetics · doi:10.4161/epi.22333 · Cited by 41
Norollahi, S. E., Mansour‐Ghanaei, F., Joukar, F., Ghadarjani, S., Mojtahedi, K., Nejad, K. G., Hemmati, H., Gharibpoor, F., Khaksar, R., & Samadani, A. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108958 · Cited by 41
Epigenetic “bivalently marked” process of cancer stem cell‐driven tumorigenesis
Balch, C., Nephew, K. P., Huang, T. H. ‐., & Bapat, S. A. (2007) · BioEssays · doi:10.1002/bies.20619 · Cited by 41
Transcriptional alterations in glioma result primarily from DNA methylation–independent mechanismsPreprint
Court, F., Boiteux, E. L., Fogli, A., Müller-Barthélémy, M., Vaurs‐Barrière, C., Chautard, E., Pereira, B., Biau, J., Kémény, J., Khalil, T., et al. (2019) · Genome Research · doi:10.1101/gr.249219.119 · Cited by 49
DNA Repair and the Control of DNA Methylation
Schär, P., & Fritsch, O. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_3 · Cited by 40
Neumann, L. C., Weinhäusel, A., Thomas, S., Horsthemke, B., Lohmann, D. R., & Zeschnigk, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-380 · Cited by 41
Parfett, C. L. J., & Desaulniers, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061179 · Cited by 41
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Liu, Z., Ren, Y., Meng, L., Li, L., Beatson, R., Deng, J., Zhang, T., Liu, J., & Han, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772211 · Cited by 42
H3K27me3-H3K4me1 transition at bivalent promoters instructs lineage specification in development
Yu, Y., Li, X., Jiao, R., Lu, Y., Jiang, X., & Li, X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01017-3 · Cited by 39
DNA methylation‐mediated nucleosome dynamics and oncogenic Ras signaling
Patra, S. K., & Szyf, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06658.x · Cited by 39
A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations
Cui, Q. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013180 · Cited by 39
DNA methylation profiling in cancer
Kondo, Y., & Issa, J. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001559 · Cited by 38
Deciphering the cancer imprintome
Monk, D. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq013 · Cited by 39
Regulation and function of mammalian DNA methylation patterns: a genomic perspective
Wu, H., Tao, J., & Sun, Y. E. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els011 · Cited by 40
Chemical Protein Degradation Approach and its Application to Epigenetic Targets
Itoh, Y. (2018) · The Chemical Record · doi:10.1002/tcr.201800032 · Cited by 41
Wang, C., Oshima, M., Sato, D., Matsui, H., Kubota, S., Aoyama, K., Nakajima‐Takagi, Y., Koide, S., Matsubayashi, J., Mochizuki‐Kashio, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94645 · Cited by 40
Epigenetic regulation of the intestinal epithelium
Elliott, E. N., & Kaestner, K. H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1997-9 · Cited by 38
Kumari, D., & Usdin, K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu378 · Cited by 38
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma
Tshuikina, M., Jernberg‐Wiklund, H., Nilsson, K., & Oberg, F. G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.08.001 · Cited by 39
Liu, Y., Hrit, J. A., Chomiak, A. A., Stransky, S., Hoffman, J. R., Tiedemann, R. L., Wiseman, A. K., Kariapper, L. S., Dickson, B. M., Worden, E. J., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.009 · Cited by 38
The role of epigenetics in colorectal cancer
Coppedè, F. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.924397 · Cited by 38
Taniguchi, H., Hoshino, D., Moriya, C., Zembutsu, H., Nishiyama, N., Yamamoto, H., Kataoka, K., & Imai, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16776 · Cited by 38
Lorzadeh, A., Romero-Wolf, M., Goel, A., & Jadhav, U. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.036 · Cited by 40
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
Marchesi, I., & Bagella, L. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.135 · Cited by 38
Epigenetic alterations in cancer and personalized cancer treatment
Miozzo, M. R., Vaira, V., & Sirchia, S. M. (2015) · Future Oncology · doi:10.2217/fon.14.237 · Cited by 37
Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma
Avissar-Whiting, M., Koestler, D. C., Houseman, E. A., Christensen, B. C., Kelsey, K. T., & Marsit, C. J. (2011) · Epigenetics · doi:10.4161/epi.6.6.16158 · Cited by 37
Synergistic chromatin repression of the tumor suppressor geneRARBin human prostate cancers
Moison, C., Assemat, F., Daunay, A., Tost, J., Guieysse‐Peugeot, A., & Arimondo, P. B. (2014) · Epigenetics · doi:10.4161/epi.27869 · Cited by 40
Huidobro, C., Toraño, E. G., Fernández, A. F., Urdinguio, R. G., Rodríguez, R. M., Ferrero, C., Martínez‐Camblor, P., Boix, L., Bruix, J., García‐Rodríguez, J. L., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1010-8 · Cited by 37
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis
Locke, W. J., & Clark, S. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3237 · Cited by 36
Martín-Trujillo, Á., Vidal, E., Monteagudo, A., Sánchez-Delgado, M., Morán, S., Mora, J. R. H., Heyn, H., Guitart, M., Esteller, M., & Monk, D. (2017) · Nature Communications · doi:10.1038/s41467-017-00639-9 · Cited by 37
Decottignies, A., & di Fagagna, F. D. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.003 · Cited by 37
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
Berry, N. B., & Bapat, S. A. (2008) · Journal of Ovarian Research · doi:10.1186/1757-2215-1-8 · Cited by 35
DNA methylation associated with polycomb repression in retinoic acid receptor β silencing
Moison, C., Sénamaud‐Beaufort, C., Fourrière, L., Champion, C., Ceccaldi, A., Lacomme, S., Daunay, A., Tost, J., Arimondo, P. B., & Guieysse‐Peugeot, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-210971 · Cited by 38
As time flies by: Investigating cardiac aging in the short-lived Drosophila model
Blice‐Baum, A. C., Guida, M. C., Hartley, P. S., Adams, P. D., Bodmer, R., & Cammarato, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.010 · Cited by 41
Neural cell state shifts and fate loss in ageing and age-related diseases
Traxler, L., Lucciola, R., Herdy, J. R., Jones, J. R., Mertens, J., & Gage, F. H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00815-0 · Cited by 37
Andersen, G. B., & Tost, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7481-8_1 · Cited by 36
Targets and genomic constraints of ectopic Dnmt3b expression
Zhang, Y., Charlton, J., Karnik, R., Beerman, I., Smith, Z. D., Gu, H., Boyle, P., Mi, X., Clement, K., Pop, R., et al. (2018) · eLife · doi:10.7554/elife.40757 · Cited by 37
ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
Kim, E. H., Cao, D., Mahajan, N. P., Andriole, G. L., & Mahajan, K. N. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa018 · Cited by 37
Improved detection of tumor suppressor events in single-cell RNA-Seq data
Teschendorff, A. E., & Wang, N. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-00151-y · Cited by 33
Charting the dynamic epigenome during B-cell development
Martín-Subero, J. I., & Oakes, C. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.008 · Cited by 41
Blancafort, P., Jin, J. J., & Frye, S. V. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080697 · Cited by 34
Yamashita, S., Nanjo, S., Rehnberg, E., Iida, N., Takeshima, H., Ando, T., Maekita, T., Sugiyama, T., & Ushijima, T. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0789-8 · Cited by 34
Carlier, F., Li, M., Maroc, L., Debuchy, R., Souaid, C., Noordermeer, D., Grognet, P., & Malagnac, F. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00395-7 · Cited by 32
da Costa, W. H., Rocha, R. M., da Cunha, I. W., Fonseca, F. P., Guimarães, G. C., & Zéqui, S. D. C. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0769-x · Cited by 34
Atkinson, S. P., Koch, C. M., Clelland, G. K., Willcox, S., Fowler, J. C., Stewart, R., Lako, M., Dunham, I., & Armstrong, L. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0497 · Cited by 34
Chromatin‐modifying proteins in cancer
Fog, C. K., Jensen, K. T., & Lund, A. H. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_776.xml.x · Cited by 35
Gebhard, C., Glatz, D., Schwarzfischer, L., Wimmer, J., Stasik, S., Nuetzel, M., Heudobler, D., Andreesen, R., Ehninger, G., Thiede, C., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0165-2 · Cited by 34
Structural biology-based insights into combinatorial readout and crosstalk among epigenetic marks
Du, J., & Patel, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.011 · Cited by 32
Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression
Zheng, J., Xiong, D., Sun, X., Wang, J., Hao, M., Ding, T., Xiao, G., Wang, X., Mao, Y., Fu, Y., et al. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0103-1 · Cited by 32
Arai, E., & Kanai, Y. (2010) · Epigenomics · doi:10.2217/epi.10.16 · Cited by 33
Oittinen, M., Popp, A., Kurppa, K., Lindfors, K., Mäki, M., Kaikkonen, M. U., & Viiri, K. M. (2016) · Stem Cells · doi:10.1002/stem.2479 · Cited by 33
Principles of Epigenetic Homeostasis Shared Between Flowering Plants and Mammals
Williams, B. P., & Gehring, M. A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.06.019 · Cited by 35
Gagliardi, A., Dugué, P., Nøst, T. H., Southey, M. C., Buchanan, D. D., Schmidt, D. F., Makalic, E., Hodge, A. M., English, D. R., Doo, N. W., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0451 · Cited by 31
Funata, S., Matsusaka, K., Yamanaka, R., Yamamoto, S., Okabe, A., Fukuyo, M., Aburatani, H., Fukayama, M., & Kaneda, A. (2017) · Oncotarget · doi:10.18632/oncotarget.19423 · Cited by 33
Epigenetic and Epigenomic Mechanisms Shape Sarcoma and Other Mesenchymal Tumor Pathogenesis
Bennani-Baïti, I. M. (2011) · Epigenomics · doi:10.2217/epi.11.93 · Cited by 32
ConteXt of change—X inactivation and disease
Agrelo, R., & Wutz, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900053 · Cited by 33
Severson, P. L., Tokar, E. J., Vrba, L., Waalkes, M. P., & Futscher, B. (2012) · Epigenetics · doi:10.4161/epi.22163 · Cited by 33
Takeshima, H., Ikegami, D., Wakabayashi, M., Niwa, T., Kim, Y.-J., & Ushijima, T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs294 · Cited by 32
The multi-omic landscape of transcription factor inactivation in cancer
Teschendorff, A. E., Zheng, S., Feber, A., Yang, Z., Beck, S., & Widschwendter, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0342-8 · Cited by 30
Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies
Oakes, C. C., & Martín-Subero, J. I. (2018) · Blood · doi:10.1182/blood-2018-02-692970 · Cited by 33
DNA methylation correlates of chronological age in diverse human tissue types
Jain, N., Li, J., Lin, T., Jasmine, F., Kibriya, M. G., Demanelis, K., Oliva, M., Chen, L., & Pierce, B. L. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00546-6 · Cited by 33
Epigenetic silencing ofNTSR1is associated with lateral and noninvasive growth of colorectal tumors
Kamimae, S., Yamamoto, E., Kai, M., Niinuma, T., Yamano, H.-O., Nojima, M., Yoshikawa, K., Kimura, T., Takagi, R., Harada, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5034 · Cited by 34
Yao, J., Zhang, L., Zhang, X., He, Z., Ma, Y., Hui, L., Wang, X., & Hu, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077974 · Cited by 31
Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
Markouli, M., Strepkos, D., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020540 · Cited by 33
Lin, H., Hung, S., Lee, M., Chiou, W., Huang, T., Tseng, C.-E., Shih, L.-Y., Lin, R.-I., Lin, J. M. J., Lai, Y.-H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2821 · Cited by 31
Stem Cell Plasticity in Development and Cancer: Epigenetic Origin of Cancer Stem Cells
Shah, M., & Allegrucci, C. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_24 · Cited by 33
Wong, C., Wong, C. C., Ng, Y., Au, S. L., Ko, F. C. F., & Ng, I. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016702 · Cited by 31
Bragado, P., Estrada, Y. D., Sosa, M. S., Avivar‐Valderas, A., Cannan, D., Genden, E., Teng, M. S., Ranganathan, A. C., Wen, H., Kapoor, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029974 · Cited by 31
Hypermethylation of the Polycomb Group Target Gene PCDH7 in Bladder Tumors from Patients of All Ages
Beukers, W., Hercegovac, A., Vermeij, M., Kandimalla, R., Blok, A. C., van der Aa, M. N. M., Zwarthoff, E. C., & Zuiverloon, T. C. M. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.01.078 · Cited by 31
Pharmacologic down-regulation of EZH2 suppresses bladder cancerin vitroandin vivo
Tang, S., Huang, H., Wu, H.-U., Tsai, Y.-T., Chuang, M., Yu, C., Huang, S.-M., Sun, G.-H., Chang, S.-Y., Hsiao, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1867 · Cited by 31
H3K4 Acetylation, H3K9 Acetylation and H3K27 Methylation in Breast Tumor Molecular Subtypes
Judes, G., Dagdemir, A., Karslı-Çeppioğlu, S., Lebert, A., Echegut, M., Ngollo, M., Bignon, Y., Penault-Llorca, F. M., & Bernard-Gallon, D. J. (2016) · Epigenomics · doi:10.2217/epi-2016-0015 · Cited by 31
Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
Fernández, A. F., Bayón, G. F., Sierra, M., Urdinguio, R. G., Toraño, E. G., García, M. G., Carella, A., López, V., Santamarina‐Ojeda, P., Pérez, R. F., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy214 · Cited by 33
Deshmukh, A. P., Arfuso, F., Newsholme, P., & Dharmarajan, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.016 · Cited by 31
Epigenetics: A way to understand the origin and biology of testicular germ cell tumors
Okamoto, K. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.02986.x · Cited by 30
EZH2: novel therapeutic target for human cancer
Li, L. (2014) · Biomedicine · doi:10.7603/s40681-014-0001-6 · Cited by 30
Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer
Cathcart, M., Gray, S. G., Baird, A., Boyle, E., Gately, K. A., Kay, E. W., Cummins, R., Pidgeon, G. P., & O'Byrne, K. J. (2011) · Cancer · doi:10.1002/cncr.26168 · Cited by 30
Replication stress, a source of epigenetic aberrations in cancer?
Jasencakova, Z., & Groth, A. (2010) · BioEssays · doi:10.1002/bies.201000055 · Cited by 29
Cellular Heterogeneity–Adjusted cLonal Methylation (CHALM) improves prediction of gene expression
Xu, J., Shi, J., Cui, X., Cui, Y., Li, J. J., Goel, A., Chen, X., Issa, J. J., Su, J., & Li, W. (2021) · Nature Communications · doi:10.1038/s41467-020-20492-7 · Cited by 31
Metadata
- Authors
- Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., Berman, D. M., Jenuwein, T., Pruitt, K., Sharkis, S. J., Watkins, D. N., Herman, J. G., & Baylin, S. B.
- Affiliations
- Johns Hopkins University (US)
- Research Institute of Molecular Pathology (AT)
- Corresponding author
- Baylin, Stephen B
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-01-09
- Volume
- 39
- Issue
- 2
- Pages
- 237-242
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2744394
- OpenAlex
- W2170210082
- Cited by
- 1,130
- References
- 30
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 33 · 2023: 53 · 2022: 33 · 2021: 56 · 2020: 38 · 2019: 36 · 2018: 27 · 2017: 50 · 2016: 57 · 2015: 54 · 2014: 70 · 2013: 82 · 2012: 105
- FWCI
- 40.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01hl073781-10)
- Sidney Kimmel Comprehensive Cancer Center
- Sidney Kimmel Center for Prostate and Urologic Cancers
- National Heart, Lung, and Blood Institute (HL073781)
- National Cancer Institute (R01CA116160, CA116160, R01CA043318, CA 043318)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- tumor suppressor, DNA hypermethylation, chromatin, embryonic stem cells, embryonal carcinoma cells, H3K27 methylation, Polycomb group proteins, H3K4 methylation, H3K9 dimethylation, H3K9 trimethylation, CpG island hypermethylation, transcriptional silencing, stem cells, tumor initiation and progression
- MeSH terms
- Adult, Chromatin, Histones, Humans, Promoter Regions, Genetic, Repressor Proteins, Stem Cells, Tumor Cells, Cultured, Genes, Tumor Suppressor, DNA Methylation, Gene Silencing, Cell Proliferation, Embryonic Stem Cells, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review